EN
HI
Summary
As of 31 Oct, 2026, Glenmark Pharmaceuticals stock price is ₹2298.7. During the trading session, the stock has moved between an intraday low of ₹2291.30 and an intraday high of ₹2337.30. Over the last 52 weeks, Glenmark Pharmaceuticals has traded between ₹1801.40 and ₹2537.60.
The stock has recorded a trading volume of 4,28,887 shares,. Its Average Traded Price (ATP) is ₹2313.93, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹2298.70.
Glenmark Pharmaceuticals has an upper circuit limit of ₹2572.90 and a lower circuit limit of ₹2105.10. The total value traded stands at ₹99.24 CR, and the delivery percentage for the day is 38.68%.
The stock is currently traded with a market lot size of 1. Glenmark Pharmaceuticals also offers a dividend yield of 0.11%.
Glenmark Pharmaceuticals Share Price Chart
Glenmark Pharmaceuticals Share Key Metrics
Volume
4.29 L
Market Cap
64874.99 CR
LTQ@LTP
1@2298.70
ATP
2313.93
Var Margin
15.14 %
Circuit Range
2105.1-2572.9
Delivery %
38.68 %
Value
99.24 CR
ASM/GSM
No
Market Lot
1
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
36.62
P/B Ratio
6.01
Div. Yield
0.11
Sector P/E
39.93
Sector P/B
3.3
Sec. Div. Yield
0.53
Glenmark Pharmaceuticals Resistance and Support
Pivot 2324.43
Resistance
First Resistance
2353.56
Second Resistance
2368.13
Third Resistance
2397.26
Support
First Support
2309.86
Second Support
2280.73
Third Support
2266.16
Glenmark Pharmaceuticals Futures & Options
Glenmark Pharmaceuticals Option Chain
View Price, OI, Greeks & More...
23NOV26
2321.70
-21.10 (0.90%)
29DEC26
2332.90
-18.50 (0.79%)
25JAN27
2351.00
49.80 (2.16%)
GLENMARK|23NOV26 CE 2280.00
97.25
-10.5 (-9.74%)
GLENMARK|23NOV26 PE 2300.00
63.95
7.7 (13.69%)
Glenmark Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 30 2026 | 2336 | 2298.7 | -1.72% | 2337.3 | 2291.3 |
| Thu Oct 29 2026 | 2311 | 2339 | 1.70% | 2339 | 2295.3 |
| Wed Oct 28 2026 | 2268 | 2300 | 1.51% | 2318 | 2261.89 |
Glenmark Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-26 | Interim Dividend |
| 2025-08-14 | Quarterly Results |
| 2025-05-23 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Ltd - 532296 - Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of Glenmark Pharmaceuticals Limited ('The Company') For The Quarter And Half Year Ended September 30, 2026
Glenmark Pharmaceuticals board to meet on November 5, 2026 for financial results. The meeting will cover performance for the quarter and half year ended September 30, 2026.
Oct 23 2026 11:44:11
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark launched Adapalene Gel USP 0.1% OTC in new pump packs in the US. The target market for this product (Differin Gel 0.1%) has annual sales of approximately $45.8 million. The launch strengthens the company's US dermatology portfolio.
Oct 06 2026 08:39:28
Glenmark Pharmaceuticals Management
| Name | Position |
|---|---|
| Rashmi Khandelwal | Company Secretary & Compliance Officer |
| Glenn Saldanha | Chairman & Managing Director |
Glenmark Pharmaceuticals Similar Stocks
Mankind Pharma Ltd.
2492.80
23.50 (0.95%)
Aurobindo Pharma Ltd.
1681.40
21.50 (1.30%)
Lupin Ltd.
2011.00
21.10 (1.06%)
Manipal Health Enterprises Ltd.
669.15
30.35 (4.75%)
Max Healthcare Institute Ltd.
860.00
8.85 (1.04%)
Alkem Laboratories Ltd.
5113.50
34.50 (0.68%)
Aster DM Quality Care Ltd.
681.15
1.95 (0.29%)
Fortis Healthcare Ltd.
768.15
13.25 (1.76%)
Biocon Ltd.
351.80
-0.10 (0.03%)
Abbott India Ltd.
25635.00
-510.00 (1.95%)
Glenmark Pharmaceuticals FAQs
The Buying Price of Glenmark Pharmaceuticals share is 2298.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glenmark Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glenmark Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glenmark Pharmaceuticals shares is 36.62. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glenmark Pharmaceuticals shares is 6.01. Useful to assess the stock's value relative to its book value.
To assess Glenmark Pharmaceuticals’s valuation compare Sector P/E, P/B which are 39.93 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glenmark Pharmaceuticals is 64874.99 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glenmark Pharmaceuticals share price is 2537.60 & 1801.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glenmark Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GLENMARK
